tiprankstipranks
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1

Compare Pharmaron Beijing Co., Ltd. Class H (17Q1) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharmaron Beijing Co., Ltd. Class H
€2.56
€6.45B
18.63
61.70%
4 Buy
0 Hold
0 Sell
Strong Buy
Genscript Biotech
HK$12.81
HK$27.88B
-6.48
27.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Zai Lab Ltd
HK$16.25
HK$18.39B
-10.93
-25.46%
8 Buy
1 Hold
0 Sell
Strong Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$24.94
HK$39.86B
-22.62
83.11%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.74
HK$35.66B
20.38
74.59%
3 Buy
0 Hold
0 Sell
Strong Buy
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
HK$73.80
HK$48.78B
17.07
120.50%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:17Q1
Pharmaron Beijing Co., Ltd. Class H
2.28
0.86
60.56%
HK:1548
Genscript Biotech
12.81
2.19
20.62%
HK:9688
Zai Lab Ltd
16.25
-8.10
-33.26%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
24.94
9.76
64.30%
HK:2096
Simcere Pharmaceutical Group Limited
13.74
5.70
70.90%
HK:6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
96.80
52.43
118.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts